human
papillomavirus
hpv
dna
tumour
virus
infect
keratinocyt
epithelia
type
identifi
classifi
either
lowrisk
highrisk
depend
associ
risk
cancer
develop
highrisk
viru
respons
approxim
cervic
cancer
viru
infect
cell
basal
layer
cervic
epithelia
site
wound
although
major
infect
clear
immun
system
persist
infect
lead
develop
cancer
cellular
transform
initi
deregul
express
viral
oncogen
highrisk
shown
promot
degrad
tumour
suppressor
bind
destabilis
cell
cycl
control
protein
prb
bind
hypophosphoryl
form
prb
inhibit
interact
transcript
factor
lead
deregul
progress
sphase
cell
cycl
addit
well
characteris
role
shown
interact
cellular
protein
includ
tata
bind
protein
tbp
recent
report
select
rna
aptam
use
novel
molecular
tool
aptam
short
nucleic
acid
fold
complex
three
dimension
structur
bind
target
molecul
conformationdepend
manner
aptam
potenti
rival
antibodi
mani
applic
due
high
bind
affin
abil
discrimin
close
relat
target
furthermor
small
therefor
reach
target
may
inaccess
antibodi
nucleic
acid
aptam
singlestrand
oligonucleotid
wherea
peptid
aptam
compos
variabl
peptid
loop
attach
protein
scaffold
former
advantag
abl
undergo
multipl
round
denatur
refold
addit
nonimmunogen
synthesis
high
puriti
modifi
number
way
increas
stabil
exampl
inclus
modifi
nucleotid
produc
vitro
virtual
target
process
known
systemat
evolut
ligand
exponenti
enrich
selex
deliv
live
cell
lipofect
case
certain
aptam
also
shown
internalis
receptormedi
endocytosi
open
mani
avenu
develop
novel
therapeut
well
tool
investig
protein
function
unlik
sirna
act
level
mrna
affect
protein
express
nucleic
acid
aptam
act
directli
protein
molecul
thu
allow
finer
control
aptam
gener
varieti
viral
protein
includ
hcv
proteas
polymeras
sar
coronaviru
helicas
influenza
ha
fmdv
polymeras
sever
hiv
protein
includ
revers
transcriptas
transactiv
protein
tat
rna
aptam
stabilis
nucleas
spontan
degrad
inclus
modifi
pyrimidin
select
sequenc
individu
clone
found
group
famili
base
sequenc
similar
sever
repres
clone
screen
bind
one
highest
affin
binder
aptam
select
studi
sequenc
predict
secondari
structur
lowest
energi
structur
shown
figur
show
molecul
inhibit
cellular
prolifer
via
induct
apoptosi
cervic
carcinoma
cell
line
siha
activ
express
control
cell
line
hacat
keratinocyt
cell
line
cervic
carcinoma
cell
line
deriv
hpvneg
cancer
cell
line
hela
also
demonstr
aptam
bind
region
requir
interact
prb
capabl
block
interact
cellular
prb
vitro
furthermor
transfect
cervic
cancer
cell
line
caski
aptam
appear
result
loss
oncoprotein
rise
cellular
prb
level
previous
report
select
rna
aptam
oncogen
protein
demonstr
aptam
bind
vitro
order
assess
effect
cell
express
cell
growth
rate
analys
siha
cell
select
studi
cell
constitut
express
cell
deriv
human
cervic
carcinoma
copi
genom
integr
chromosom
hacat
immortalis
keratinocyt
cell
use
neg
control
cell
transfect
nm
analys
hour
mtt
assay
signific
chang
cell
viabil
measur
hour
figur
howev
siha
cell
transfect
reduc
cell
viabil
hour
compar
mocktransfect
cell
reduct
alter
growth
detect
hacat
cell
figur
observ
confirm
use
realtim
cell
electron
sens
rtce
system
xcellig
roch
measur
cellular
prolifer
via
electr
imped
confer
microelectrod
array
brief
cell
allow
adher
microelectrodeco
plate
hour
prior
transfect
either
aptam
select
unrel
protein
rnadependentrna
polymeras
fmdv
neg
control
refer
aptam
contain
primer
sequenc
differ
random
region
thu
share
similar
predict
lowest
energi
structur
shown
figur
note
modif
affect
pucker
ribos
taken
account
fold
algorithm
therefor
predict
structur
approxim
may
accur
repres
aptam
structur
solut
cellular
prolifer
rate
measur
triplic
chang
electr
imped
cell
index
time
figur
f
transfect
perform
serumfre
media
hour
correspond
rapid
drop
imped
arrow
howev
return
approxim
pretransfect
level
case
upon
addit
serum
arrow
ii
siha
hacat
cell
mocktransfect
lipofect
reagent
alon
continu
prolifer
time
howev
prolifer
rate
fell
rapidli
cell
treat
staurosporin
induc
apoptosi
subsequ
small
rise
cell
index
observ
siha
cell
consist
cell
surviv
staurosporin
treatment
transfect
siha
cell
aptam
caus
cell
index
decreas
time
figur
effect
rapid
cell
transfect
nm
decreas
cell
index
commenc
hour
posttransfect
hour
cell
index
fallen
reduc
concentr
delay
onset
effect
cell
index
siha
cell
transfect
nm
begin
decreas
hour
posttransfect
respect
reach
level
seen
nm
hour
posttransfect
dosedepend
decreas
cell
index
nm
respect
slight
increas
cell
index
record
immedi
recoveri
serum
like
reflect
chang
cell
morpholog
adhes
consist
induct
apoptosi
studi
use
system
analysi
cytotox
compound
observ
similar
cell
index
profil
contrast
hacat
cell
express
unaffect
concentr
test
figur
furthermor
neg
control
aptam
signific
effect
prolifer
either
siha
hacat
cell
figur
f
respect
chang
cell
index
measur
rtce
greater
chang
viabil
measur
mtt
assay
could
reflect
insensit
latter
realtim
cell
sens
assay
may
overestim
reduct
cell
growth
chang
cell
morpholog
appear
siha
cell
transfect
indic
induct
apoptosi
whilst
hacat
cell
appear
unaffect
figur
quantifi
observ
apoptosi
assay
perform
siha
cell
transfect
increas
concentr
aptam
nm
hour
sampl
stain
fitcconjug
annexin
v
propidium
iodid
identifi
apoptot
cell
flow
cytometri
small
increas
apoptosi
induc
siha
cell
transfect
control
aptam
nm
nm
respect
figur
howev
level
apoptosi
cell
transfect
greater
apoptosi
nm
nm
respect
figur
concentr
use
level
total
apoptosi
increas
doserespons
manner
significantli
higher
induc
p
p
respect
due
increas
earli
late
apoptosi
hour
transfect
level
apoptosi
therefor
account
larg
proport
observ
decreas
growth
siha
cell
hour
posttransfect
nm
shown
figur
although
small
increas
apoptosi
seen
hacat
cell
signific
differ
level
induc
figur
contrast
observ
siha
cell
note
although
hacat
hpvneg
cell
line
deriv
cervic
carcinoma
therefor
extend
studi
includ
two
addit
cervic
carcinoma
cell
line
hela
cell
cell
hpvneg
figur
demonstr
small
effect
level
apoptosi
measur
hela
cell
howev
neither
increas
significantli
differ
like
result
nonspecif
respons
presenc
rna
data
also
indic
hpvtype
specif
appear
littl
effect
cell
howev
experi
would
necessari
confirm
note
innat
immun
respons
hela
cell
shown
much
reduc
compar
cell
therefor
result
seen
due
exclus
innat
immun
would
expect
see
greater
effect
hela
cell
would
also
expect
see
similar
effect
siha
cell
contrast
data
collect
suggest
effect
siha
cell
prolifer
least
part
due
induct
target
apoptosi
similar
effect
seen
hacat
hela
cell
hacat
cell
use
control
cell
line
experi
three
conserv
region
shown
bind
prb
via
lxcxe
motif
conserv
region
figur
contrast
bind
involv
residu
well
residu
lxcxe
motif
bind
tbp
requir
residu
zincbind
domain
identifi
region
protein
involv
interact
panel
mutant
protein
express
e
coli
purifi
figur
bind
assay
perform
previous
report
brief
purifi
protein
bound
glutathionemagnet
gm
bead
incub
label
percentag
bound
aptam
determin
scintil
count
bound
unbound
fraction
although
maxim
bind
achiev
experi
compar
data
qualit
manner
seen
bind
moder
affect
small
delet
zincbind
domain
howev
bind
abrog
point
mutat
residu
within
lxcxe
motif
posit
figur
indic
bind
nterminu
furthermor
chang
seen
bind
result
point
mutationsdelet
provid
support
interact
specif
rather
act
gener
rnabind
protein
aptam
prb
protein
requir
residu
ntermin
region
bind
predict
aptam
might
disrupt
interact
prb
inde
previou
preliminari
studi
demonstr
abil
interfer
interact
prb
therefor
carri
gst
pulldown
assay
quantifi
effect
figur
b
experi
use
hacat
cell
lysat
cell
express
would
therefor
provid
sourc
prb
absenc
endogen
could
interfer
bind
assay
hacat
lysat
lane
incub
immobilis
onto
gmbead
absenc
lane
prb
precipit
howev
increas
concentr
lane
amount
prb
precipit
reduc
gst
alon
interact
prb
either
absenc
presenc
lane
respect
data
confirm
abl
disrupt
interact
vitro
dosedepend
manner
highest
concentr
test
figur
investig
effect
interact
perform
coimmunoprecipit
assay
presenc
absenc
aptam
analysi
nm
transfect
caski
cell
cervic
cancer
cell
line
contain
sever
hundr
copi
genom
cell
express
approxim
higher
level
siha
cell
watherston
per
comm
note
high
level
express
caski
cell
meant
possibl
deliv
suffici
aptam
order
detect
statist
signific
level
apoptosi
figur
howev
level
suffici
detect
immunoblot
thu
allow
effect
aptam
determin
transfect
cell
incub
hour
follow
prepar
cell
lysat
immunoprecipit
antibodi
prb
experi
therefor
allow
quantif
level
prb
two
way
coimmunoprecipit
comparison
input
level
hour
incub
aptam
mocktransfect
sampl
effici
coimmunoprecipit
observ
use
antiprb
figur
lane
respect
howev
nm
transfect
cell
coimmunoprecipit
antiprb
reduc
compar
lane
mirror
reduct
input
level
cell
transfect
hour
figur
lane
transfect
reduc
level
cell
compar
lane
whilst
cell
receiv
control
level
reduc
compar
lane
reduct
level
correl
increas
cellular
prb
total
level
prb
cell
transfect
nm
hour
increas
compar
prb
doublet
lane
howev
cell
lysat
immunoprecipit
differ
level
coimmunoprecipit
prb
treatment
lane
possibl
due
high
level
express
cell
coupl
concentr
antibodi
bind
investig
level
caski
cell
presenc
absenc
aptam
investig
caski
cell
transfect
aptam
incub
hour
level
detect
immunoblot
figur
show
cell
either
mocktransfect
lane
transfect
control
aptam
lane
level
significantli
higher
cell
transfect
lane
densitometri
analysi
independ
experi
figur
show
caski
cell
transfect
level
reduc
lane
cell
level
reduc
lane
togeth
result
indic
hour
incub
lost
cell
experi
also
perform
investig
effect
level
endogen
prb
result
transfect
prb
level
elev
although
degre
variabl
level
detect
averag
almost
threefold
increas
mock
transfect
measur
shown
figur
e
compar
lane
transfect
control
aptam
lane
littl
effect
rna
aptam
current
employ
tool
investig
varieti
viral
cellular
protein
also
develop
diagnost
antivir
agent
characteris
rna
aptam
term
select
oncoprotein
transfect
cell
line
siha
result
decreas
cell
viabil
induct
apoptosi
aptam
abl
inhibit
interact
prb
vitro
upon
investig
appear
transfect
caski
cell
molecul
result
reduct
level
loss
appear
correl
increas
level
prb
howev
known
whether
affect
level
relat
pocket
protein
pro
antiapoptot
effect
report
literatur
data
consist
antiapoptot
effect
siha
caski
cell
extrem
unstabl
cell
rapidli
ubiquitin
degrad
via
proteasom
protein
highrisk
hpv
high
degre
intrins
protein
disord
especi
prbbind
nterminu
greater
display
protein
lowrisk
type
flexibl
may
contribut
abil
bind
varieti
protein
possibl
inhibit
critic
interact
could
result
instabl
degrad
thu
allow
restor
prb
level
although
appear
result
report
result
disrupt
interact
vitro
unclear
also
occur
context
cell
therefor
possibl
bind
directli
induc
loss
result
restor
prb
level
previou
studi
shown
express
constitutivelyact
prb
cervic
cancer
cell
line
result
induct
apoptosi
suggest
loss
detect
upon
transfect
result
releas
activ
prb
ultim
result
apoptot
respons
remain
possibl
slight
increas
apoptosi
seen
control
aptam
due
presenc
modifi
nucleotid
innat
rna
sens
howev
effect
small
comparison
effect
therefor
main
mode
action
unlik
result
innat
immun
respons
aptam
rna
interestingli
similar
result
report
observ
use
sirna
although
protein
level
measur
directli
increas
hypophosphoryl
prb
demonstr
correl
induct
apoptosi
howev
other
also
observ
differ
effect
sirna
eg
growth
arrest
note
mode
action
sirna
molecul
interfer
protein
synthesi
translat
level
express
singl
bicistron
mrna
use
sirna
result
downregul
protein
offtarget
effect
possibl
explain
differ
result
document
although
offtarget
effect
remain
possibl
demonstr
littl
effect
three
cell
line
hela
hacat
use
pulldown
assay
also
demonstr
effect
interact
data
shownbelyaeva
et
al
prepar
data
also
support
sever
report
proapoptot
effect
peptid
furthermor
one
molecul
demonstr
act
via
reactiv
pathway
consist
effect
rna
aptam
describ
although
peptid
aptam
costli
produc
high
puriti
togeth
studi
demonstr
power
approach
develop
potenti
novel
therapeut
recent
separ
studi
identifi
rna
aptam
although
characteris
cell
work
illustr
potenti
technolog
use
aptam
specif
molecular
tool
therefor
like
help
dissect
pathway
understand
complex
role
previou
studi
demonstr
small
sequenc
variat
affect
abil
aptam
affect
interact
characteris
may
identifi
minim
bind
region
thu
allow
gener
smaller
molecul
cheaper
easier
produc
work
ongo
characteris
aptam
select
pool
aptam
target
oncoprotein
like
addit
effect
studi
also
ongo
investig
pathway
loss
specif
aptam
aptam
deliveri
primari
cell
aptam
technolog
thu
potenti
provid
new
insight
multipl
molecular
interact
perform
small
viral
oncoprotein
express
purif
undertaken
follow
previou
publish
protocol
express
vector
point
mutat
delet
also
describ
previous
siha
caski
hela
hpvposit
human
cervic
cancerderiv
hpvneg
human
cervic
cancerderiv
hacat
immortalis
keratinocyt
cell
maintain
dmem
supplement
vv
fc
unitsml
penicillin
mgml
streptomycin
wv
glutamin
vv
antibodi
use
antiprb
new
england
biolab
abcam
santa
cruz
antigst
cambridg
bioscienc
rabbit
antiprb
merck
chemic
antigapdh
sigma
aldrich
vitro
select
perform
use
biomek
autom
workstat
beckman
coulter
describ
previous
vitro
transcript
reaction
carri
includ
trilink
biotechnolog
use
mutant
rna
polymeras
accord
method
report
previous
share
region
ie
sequenc
region
cccuucaucauuaacccguccacgcgc
ucggcucaaaaauacguccgcaccauaca
respect
cell
seed
well
hour
prior
transfect
nm
describ
maintain
hour
cell
harvest
trypsinis
wash
twice
pb
suspend
ice
cold
annexin
v
buffer
mm
hepeskoh
ph
mm
nacl
mm
fitcconjug
annexin
v
incub
ice
minut
cell
costain
propidium
iodid
pb
analys
use
facscalibur
cellquest
pro
softwar
becton
dickinson
radiolabel
aptam
rna
gener
endlabel
atp
unincorpor
nucleotid
remov
column
purif
nucaway
spin
column
ambion
label
rna
incub
proteinload
gmbead
final
concentr
nm
minut
room
temperatur
proteinload
bead
bound
rna
isol
reaction
mixtur
supernat
transfer
scintil
fluid
unbound
fraction
bead
wash
three
time
pb
suspend
scintil
fluid
bound
fraction
method
base
previous
report
protocol
gst
protein
bound
gmbead
cell
lysat
prepar
describ
previous
incub
hour
bead
isol
wash
sampl
analys
immunoblot
use
antigst
mous
antiprb
cell
plate
transfect
nm
aptam
use
oligofectamin
cell
lyse
ripa
buffer
clear
centrifug
lysat
incub
antiprb
overnight
shake
antibodylys
mixtur
centrifug
remov
precipit
follow
incub
vv
protein
g
sepharos
slurri
sigma
hour
sepharos
collect
centrifug
wash
ripa
buffer
three
time
resuspens
sdspage
load
buffer
analysi
immunoblot
standard
error
includ
student
ttest
perform
obtain
pvalu
appropri
